Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Ravi Ramani, MD

Ravi Ramani, MD

  • Chief Quality Officer, Harrington Heart and Vascular Institute, University Hospitals
  • Clinical Chief, Cardiovascular Medicine for Academic Affairs, UH Cleveland Medical Center
  • Lorraine and Bill Dodero Chair in Heart Failure and Transplantation, University Hospitals
  • Specialty: Cardiology-Heart Failure, Cardiology
  • Location:
    UH Parma Medical Arts Building 3
    6525 Powers Blvd
    Parma, OH 44129

Biography: Ravi Ramani, MD

Certifications & Memberships

  • Advanced Heart Failure and Transplant Cardiology - American Board of Internal Medicine
  • Cardiovascular Disease - American Board of Internal Medicine

Education

Fellowship | Heart Failure and Cardiac Transplantation
Heart Failure and Cardiac Transplantation - University Of Pittsburgh Medical Center UPMC (2002 - 2003)

Fellowship | Cardiology
Cardiology - University Of Pittsburgh Medical Center UPMC (1999 - 2002)

Residency | Internal Medicine
Internal Medicine - Montefiore Medical Center (1996 - 1999)

Medical Education
Armed Forces Medical College, Maharashtra University Of Health Sciences (1994)

About

Ravi Ramani, MD, MMM, is an advanced heart failure specialist and serves as both Clinical Chief of Cardiovascular Medicine and Chief Quality Officer at University Hospitals Harrington Heart & Vascular Institute. He has been recognized with the Lorraine and Bill Dodero Chair in Heart Failure & Transplantation. He is also an Assistant Professor at Case Western Reserve University School of Medicine.

Dr. Ramani earned his medical degree from the Armed Forces Medical College in Pune, India. His postdoctoral training included a residency in internal medicine at Montefiore Medical Center in New York, followed by a cardiovascular disease fellowship then an advanced heart failure and transplantation fellowship at the University of Pittsburgh Medical Center (UPMC) in Pennsylvania. He later earned a Master of Medical Management (MMM) at Carnegie Mellon University.

Dr. Ramani is board certified in cardiovascular disease, advanced heart failure and transplant cardiology. He has authored more than 70 clinical publications, abstracts and book chapters on related topics in his field. He is also a peer reviewer for highly regarded professional journals including the Journal of the American Heart Association and International Journal of Cardiology.

Dr. Ramani is passionate about teaching the next generation of physicians. He has organized, facilitated and led numerous residents and fellows training in the field of cardiovascular medicine, advanced heart failure and transplant cardiology. He is also an avid researcher, as co-investigator on over 15 clinical studies related to innovative therapies and optimal care for patients with heart failure, pulmonary hypertension and cardiogenic shock, with special focus on the evaluation of advanced heart failure therapies such as ventricular assist devices (VADs) and heart transplantation.

Dr. Ramani is a member of nationally distinguished organizations including the Heart Failure Society of America, International Society of Heart and Lung Transplantation, American Medical Association and American Heart Association. He actively participates as a reviewer, session chair and moderator for American College of Cardiology national conferences. He is also an invited expert speaker, with more than 85 presentations at regional, national and international cardiovascular symposiums.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Ravi Ramani did not disclose any Outside Relationships with Industry.